Obesity Related Pathogenesis In The Short And Long Term Flashcards
1
Q
How obesity is defined and assessed
A
- definition: a complex, incompletely understood, serious and chronic disease which was part of a cluster of non-communicable diseases that required prevention and management strategies at both individual and societial level
- WHO definition: the disease in which excess body fat has accumulated to such an extent that health may be adversely affected
- diagnosed via BMI over 30, class 1 (30-34.9) class 2 (35-39.9), class 3 (>40). BMI for asians is 2.5 points lower
- waist circumference used if BMI <40
- waist/hip ratio
- body composition analysis: BIA, DEXA, MRI
- scoring system to prioritise the greatest health risk and monitor health improvement: edmonton obesity staging system (EOSS)
2
Q
The impact of obesity on health and life expectancy
A
- adipocytes enlarge and multiply and are biologically active secreting adipokines and proinflammatory cytokines: leptin, TNFa, IL6, decrease in adiponectin
- metabolic risks: asthma, fatty liver, gallstones, infertility, cancers, CVD, T2DM
- mechanical risks: reduced physical functioning, incontinence, joint diseases, sleep apnea, chronic back pain
- CNS risks: depression and anxiety
- prevalence of complications (including cancers) increases with BMI
- a BMI >40 is a high risk group for COVID
- life expectancy decreases as BMI increases: normal BMI chance of getting to 70 (80%), BMI of 35-40 60% chance, BMI of 40-50 ~50% chance
- EOSS can be used to assess those at an increased risk of dying, as it includes comorbidities and severity
3
Q
How is body weight regulated?
A
- Satiety: POMC neurons in arcuate nucleus are activated by neuropeptides such as PYY which activates MC3/4R neurons in the hypothalamus which decreases appetite. Leptin and insulin should decrease appetite too
- hunger: ghrelin release activates NPY/AgRP in the arcuate nucleus which activates Y1/Y5R in the hypothalamus causing increased appetite
- there is cross talk between the hypothalamus and the brainstem which can also lead to feeding, gastric emptying and metabolic rate
- if obese very early in life may have leptin deficiency, but most obese people have high levels of circulating leptin but are just resistant to effects
4
Q
Genetic predisposition and obesity
A
- in early life if obese may have leptin deficiency or mutation in the POMC axis but this is very rare
- body weight is highly heritable: 40-70%
- obesity risk FTO variant (SNP rs9939609) have stronger responses to food from reward systems in brain, decreased satiety, get hungry quicker after eating and have higher levels of circulating ghrelin
5
Q
Roles of lifestyle and other causal factors in development of obesity
A
- people not as active as before
- can overlay takeaway maps with obesity: chances of being obese increased if neighbourhood fast food
- psychosocial factors: feelings of isolation, abuse
6
Q
Role of gut hormones in regulating energy balance
A
- PYY (satiety) is released from gut along with ghrelin (hunger)
- if infuse patients with PYY have lower energy intake at ad libitum meal
- obese individuals have lower PYY
- PYY acts upon brain in centers that respond to eating and reward
- obese people have higher ghrelin levels
- all GI hormones have peripheral effect and act on many areas including taste
7
Q
Treatment options for obesity
A
- if lose >15% body weight highly likely to achieve remission of many obesity related chronic diseases
- diet and lifestyle changes and behavioural therapy given to all BMI over 25
- pharmacotherapy (such as orlistat) can be to those >30 BMI or >27 if additional comorbidities
- bariatric surgery offered for those >40 BMI or >35 with comorbidites
- bariatric surgery is associated with sustained weight loss and improves survival with immediate effects (ie remission from diabetes on the same day) due to changes in gut hormone axis. 25% weight loss at 5 years. 40% reduction in mortality from comorbidites
8
Q
How does bariatric surgery cause weight loss
A
- favourable gut hormone profile
- reduced hunger/appetite
- reduced preference for sweet/fat
- reduced reward value for food and correction of brain response to food cues
- improved gut microbiome
- restoration of insulin and leptin sensitivity
9
Q
Why is weight loss through dieting difficult?
A
- activates powerful compensatory pathways
- increased hunger and interest in food, reduced energy expenditure
- increased ghrelin reduced PYY
- homeostatic reward system increases in response to food
10
Q
Why obesity is recognised as a chronic disease?
A
- multi-factorial disease with many contributory factors
- increased adipose tissue increasing inflammatory cytokines
- pancreas dysfunction
- gut hormone dysfunction
- genetic susceptibility
- medications